Study of the impact of the Flash Glucose Monitoring System (FGM) on glycometabolism of newly diagnosed type 2 diabetic patients

Not Applicable

Recruiting

• Conditions: type 2 diabetes mellitus; diabetes mellitus; D003920

• Registration Number: JPRN-jRCTs042210010
• Lead Sponsor: Arima Hiroshi

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2021-04-21
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Diabetes patients who
1)are diagnosed type 2 diabetes mellitus
2)have HbA1c level of 7.0% or more and less than 8.0%
3)are 20 years of age or older
4) are not prescribed any hypoglycemic drug

Exclusion Criteria

Those who have hyperglycaemic symptoms or ketosis
Those whose anti-GAD Abs are positive
Those who have been using self-monitaring of blood glucose
THose who have preproliferative or proliferative diabetic retinopathy
Those who have severe renal failure (eGFR<30/ml/min/1.73m3)
Those who are judged by their physicians to be unsuitable for enrolling the study

Study & Design

• Study Type: Interventional
• Study Design: Not specified